Rasmussen encephalitis is a chronic inflammatory disease commonly seen in children. Hemispheric atrophy, intellectual disability, and hemiparesis are characteristics of this rare disease. The main pathological findings are chronic meningeal and parenchymal inflammation attributed to T lymphocytes. Plasmapheresis, immunomodulators, and immunosuppressives are commonly used for treatment. In this article, a patient suffering from Rasmussen encephalitis whose seizures were treated with prednisolone is discussed according to the literature.
Rasmussen encephalitis is a chronic inflammatory disease commonly seen in children (l). The disease causes progressive atrophy in one ofthe hemispheres of the brain. As a result, clinical features include cognitive dysfunction, motor deficits, and refractory seizures. Magnetic resonance imaging (MRI) demonstrates signal changes and atrophy in one hemisphere (2) . The disease is diagnosed via clinical, radiological, and electroencephalographic (EEG) findings. Immune mechanisms are thought responsible for the underlying etiology, thus plasmapheresis, immunomodulators, and immunosuppressives are used to treat a limited number of patients (3) . At present, hemispherectomy is considered the most effective treatment option (4) . We diagnosed the present case, who suffered from refractory epilepsy, with Rasmussen encephalitis and treated the patient with high dose prednisolone with the aim of controlling the seizures. In this case report, this rare disease and the efficiency of immunosuppressive treatment are discussed according to the literature.
Case report
A 19-year-old male patient presented to the emergency service in status epilepticus. He had had no particular health problems until the age of five. He was born via vaginal delivery and had cried immediately after birth. At five years of age, he had started having seizures beginning with contractions in his right arm, right leg, and face. He began to receive antiepileptic drugs, and the frequency of his seizures decreased. However, he continued to have seizures almost daily. Prior to admittance to our emergency service, especially in the previous week, he had had generalized tonic-clonic (GTC) seizures three times a day, and his clinical status had deteriorated. In the emergency service, neurological examination showed that he was unconscious and experiencing GTe seizures. Due to dyspnea and respiratory problems, he was examined by a pulmonologist. His previous medications were as follows: topiramate 200 mg/day, levetiracetam 3000 mg/day, valproic acid 1500 mg/day, carbamazepine 1200 mg/day. The patient was treated with diazepam and phenytoin IV DISCUSSION showed epileptic activity originating from the left hemisphere (Fig. 2) .
The patient had been previously referred to several clinics and had been treated with different types of antiepileptic drugs but not with any immunosuppressives or immunomodulators. According to the patient's relatives, one clinic suggested that the patient undergo a hemispherectomy operation, but the patient's relatives had refused. Since the seizures continued to occur, the patient was treated with prednisolone (1000 mg/d) for three days, and responded favorably. EEG was repeated, and no seizure activity was observed .He was discharged from the hospital with proper antiepileptics and did not have any GTC seizures for six month, although he occasionally experienced face muscle contractions. This six-month treatment period was the longest period since the age five that the patient had not experienced any GTC seizures. He is currently under treatment at our clinic.
Rasmussen encephalitis is a chronic inflammatory encephalitis, and its etiology remains unclear (5) . Hemispheric atrophy, intellectual disability, and hemiparesis are characteristics of this rare disease (6) . Rasmussen encephalitis is commonIy seen during Fig. 1 . AIR!showed a markedly atrophied left hemisphere.
childhood, but recent studies have shown that an adult infusions. After infusions, phenytoin (100 mg t.i.d.) was prescribed in addition to his previous antiepileptic drugs. The pulmonologist evaluated the patient and attributed his dyspnea to respiratory muscle spasms and fatigue of respiratory muscles caused by epileptic seizures. The patient was not found to have any acute or chronic pulmonary conditions. After treatment with the aforementioned medications, the patient's frequency of seizures decreased and his clinical status improved but sometimes he still suffered from epileptic seizures. Neurological examination showed a right motor deficit involving his right arm and hand and predominantly his right leg and foot. His cranial MRI showed a markedly atrophied left hemisphere (Fig. I) . EEG was performed, which form of the disease exists (7) . The main pathological findings are chronic meningeal and parenchymal inflammation attributed to T lymphocytes. Pathological changes lead to diffuse and nodular cell proliferation, followed by gliosis and neuronal cell death. However, the pathological mechanisms are still under discussion (8) . Several studies have suggested that antibodies against GluR3 receptors are responsible for development of the disease (9) . However, patients who were definitively diagnosed with Rasmussen encephalitis were found not to have these antibodies (8) . Currently, immunotherapy and hemispherectomy are the standard treatment options. The aim of treatment is to stop seizures and prevent cognitive deterioration and neurological deficits (10) . Some studies have demonstrated that immunomodulator treatment partially reverses motor deficits and seizures (11). Steroid treatment and plasmapheresis are other treatment options (12) . Our patient started having symptoms when he was five years old. His medical records showed that he had been referred to several clinics and had been treated with several types of antiepileptic drugs but not with any immunosuppressives or immunomodulators. Hemispherectomy was suggested as a treatment option but the patient's relatives refused the treatment.
Considering his antiepileptic drug regimen, the patient was clearly experiencing resistant seizures. Hemiatrophy was evident in cranial MRI images. Moreover, the patient had symptoms ofmotor deficits and intellectual disability. Sturge-Weber syndrome and Dyke-Davidoff-Masson syndrome have similar clinical and radiological findings and must always be kept in mind during the differential diagnosis of Rasmussen encephalitis. Sturge-Weber syndrome (SWS) is characterized by port-wine nevus, usually on the face, leptomeningeal angiomatosis and glaucoma. Neurological findings usually depend on the origin of cerebral pathology. The most common clinical findings are epilepsy and hemiparesis (13) . Dayke-Davidoff-Masson syndrome is characterized by epileptic seizures, facial asymmetry, contralateral hemiparesis or hemiplegia, and mental retardation (14) . On physical examination, our patient had no signs of port-wine nevus or glaucoma. Cortical hyperintensities are commonly seen on radiological images of Sturge-Weber syndrome cases (15) . Radiological images usually reveal thickening of the calvarium III cases with Dayke-Davidoff-Masson syndrome (14) . Imaging revealed neither in our patient, supporting the diagnosis of Rasmussen encephalitis. Treatment of Rasmussen encephalitis is still under discussion. Some studies have suggested that high-dose IVIG and steroid treatment might reduce the frequency of epileptic seizures, but the optimal dosage and treatment period are unclear (16) . We treated our patient with high-dose steroids for three days, and his seizures regressed completely.
Hemispherectomy is considered to be the most effective treatment option, but the timing of the operation is under discussion (16) . In a previous study, seizure frequency decreased more than 50 percent after the patient received a vagal nerve stimulator (17) . In another case report, destruction of astrocytes was attributed to CD8+ T lymphocytes and was ceased using natalizumab, which blocked CD8+ T lymphocyte entry into the central nervous system (18) . In our case, we also used steroid treatment, which reduced the epileptic seizures significantly.
In conclusion, we emphasize that prednisolone is able to reduce the frequency of seizures in a select patient population. In the past few years, attempts have been made to clarify the pathology of Rasmussen encephalitis, but the optimal treatment period and treatment dosage remain unclear. Further randomized controlled trials are necessary to provide more information about the treatment of Rasmussen encephalitis.
